Company Search:
Advanced Search
Sponsored Links
Alembic Pharmaceuticals Ltd Company Snapshot
Alembic Pharmaceuticals Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alembic Pharmaceuticals Ltd with three other companies in this sector in India: Strides Shasun Ltd (2016 sales of 31.38 billion Indian Rupees [US$469.73 million] of which 101% was Pharma), IPCA Laboratories Limited (28.85 billion Indian Rupees [US$431.89 million] of which 100% was Pharmaceuticals), and Glaxosmithkline Pharmaceuticals Limited (27.68 billion Indian Rupees [US$414.42 million] of which 100% was Pharmaceuticals).

Sales Analysis. Alembic Pharmaceuticals Ltd reported sales of 31.49 billion Indian Rupees (US$471.36 million) for the fiscal year ending March of 2016. This represents an increase of 53.1% versus 2015, when the company's sales were 20.56 billion Indian Rupees. Sales at Alembic Pharmaceuticals Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 166%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Alembic Pharmaceuticals Ltd
  Stock Performance Chart for Alembic Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 675.35
(Figures in Indian Rupees)
1 Week -0.9%   13 Weeks -0.5%  
4 Weeks 14.9%   52 Weeks -2.7%  
Alembic Pharmaceuticals Ltd Key Data:
  Ticker: APLLTD Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 31,487,103,000
(Year Ending Jan 2017).
Employees: 8,007
  Currency: Indian Rupees Market Cap: 127,314,222,520
  Fiscal Yr Ends: March Shares Outstanding: 188,515,914
  Share Type: Ordinary Closely Held Shares: 133,548,105
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.